V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001421 | 230001037 | 1.66 | null | Palliative (P) | 2019-01-04 | 2019-01-04 | Irinotecan + Modified De Gramont | N | N | 230004079 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 230001422 | 230001038 | null | 108 | Palliative (P) | 2018-01-06 | 2018-01-06 | Irinotecan + Modified De Gramont | N | null | 230004079 | SORAFENIB |
| 230001423 | 230001039 | 1.88 | 107 | Adjuvant (A) | 2015-05-20 | 2015-06-03 | R GCVP | N | N | 230005389 | TRASTUZUMAB |
| 230001424 | 230001039 | 1.62 | 82.3 | Curative (C) | 2019-01-22 | 2019-03-12 | Methotrexate intrathecal | 02 | null | 230005389 | OXALIPLATIN + MDG |
| 230001425 | 230001040 | 1.59 | 71 | Adjuvant (A) | 2016-06-16 | 2016-09-06 | Trial Unspecified | 02 | N | 230008991 | DOCETAXEL + TRASTUZUMAB |
| 230001426 | 230001041 | 1.7 | 61.1 | Neo-adjuvant (N) | 2016-07-24 | 2016-07-26 | Rituximab | 02 | N | 230009376 | TRASTUZUMAB |
| 230001427 | 230001042 | 1.75 | null | Adjuvant (A) | 2014-09-27 | 2014-11-30 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 230011679 | TRASTUZUMAB |
| 230001428 | 230001044 | null | 70.4 | Palliative (P) | 2018-10-28 | 2018-11-01 | Bevacizumab + Cape + Oxali 14day | N | null | 230012425 | IRINOTECAN + MDG |
| 230001429 | 230001048 | 1.73 | 78 | Adjuvant (A) | 2016-09-02 | 2016-09-03 | Capecitabine + Cisplatin + RT | 02 | N | 230012430 | OXALIPLATIN + MDG |
| 230001430 | 230001049 | 1.69 | 69.3 | Palliative (P) | 2015-01-21 | 2015-03-05 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | 230013595 | CARBOPLATIN + ETOPOSIDE |
| 230001431 | 230001049 | 1.85 | null | Palliative (P) | null | 2016-12-31 | Sorafenib | 02 | N | 230013595 | LENVATINIB |
| 230001432 | 230001050 | null | 94.5 | null | null | 2019-03-19 | FLUOROURACIL + OXALIPLATIN | N | N | 230013809 | TRASTUZUMAB |
| 230001433 | 230001051 | 1.62 | 61.3 | Not known (9) | 2018-05-26 | 2018-06-09 | Cisplatin + Etoposide (5 day) | 02 | N | 230014077 | FLUOROURACIL + MITOMYCIN + RT |
| 230001434 | 230001052 | 1.64 | 68.4 | Disease modification (D) | 2017-09-11 | 2017-09-19 | Capecitabine | N | N | 230019117 | IFOSFAMIDE |
| 230001435 | 230001439 | null | 53 | Curative (C) | 2017-01-04 | 2017-01-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | Y | 230020173 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 230001436 | 230001053 | 1.82 | 85.9 | Adjuvant (A) | 2013-12-20 | 2014-04-15 | PEMBROLIZUMAB | 2 | N | 230024525 | TRIFLURIDINE + TIPIRACIL |
| 230001437 | 230001054 | 1.6 | null | Adjuvant (A) | 2018-11-12 | 2018-11-12 | null | N | N | 230004040 | TRABECTEDIN |
| 230001438 | 230001055 | 1.7 | 84 | Palliative (P) | 2017-07-23 | 2017-09-01 | Sorafenib | N | null | 230004040 | IRINOTECAN + MDG |
| 230001439 | 230001056 | 1.65 | 82 | Palliative (P) | 2018-10-10 | 2018-10-24 | Cisplatin + Etoposide (5 day) | 02 | null | 230010972 | TRASTUZUMAB |
| 230001440 | 230001057 | 1.71 | null | Curative (C) | 2018-05-06 | 2018-06-23 | Trifluridine + Tipiracil | 99 | null | 230025405 | CARBOPLATIN + ETOPOSIDE |
| 230001441 | 230001441 | 1.73 | 79.4 | Palliative (P) | 2014-03-27 | 2015-10-26 | AML 19 TRIAL | 02 | N | 230001129 | TRASTUZUMAB |
| 230001442 | 230000623 | 1.72 | 85 | Adjuvant (A) | null | 2018-07-07 | PEMBROLIZUMAB | 02 | N | 230014716 | CAPECITABINE + OXALIPLATIN |
| 230001443 | 230000625 | 1.78 | null | Adjuvant (A) | 2016-11-23 | 2016-12-08 | Capecitabine 42days + RT | null | N | 230014751 | CAPECITABINE |
| 230001444 | 230000628 | 1.75 | 62 | Palliative (P) | 2019-01-05 | 2019-01-05 | Sorafenib | 02 | N | 230014868 | OXALIPLATIN + MDG |
| 230001445 | 230000631 | 1.57 | 76 | Palliative (P) | 2019-02-06 | 2019-02-06 | LENVATINIB | 02 | N | 230015009 | CETUXIMAB + IRINOTECAN + MDG |
| 230001446 | 230000634 | 1.71 | 73 | Palliative (P) | 2016-06-30 | 2016-07-14 | Capecitabine 35days + RT | N | N | 230015520 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 230001447 | 230000637 | null | null | Palliative (P) | 2014-09-16 | 2014-09-22 | CVP R | N | N | 230015621 | GEMCITABINE |
| 230001448 | 230000639 | 1.7 | null | Curative (C) | 2018-02-24 | 2018-02-25 | TRASTUZUMAB | 02 | null | 230016208 | OXALIPLATIN + MDG |
| 230001449 | 230000640 | null | 96.1 | Palliative (P) | 2018-05-07 | 2018-06-02 | VANDETANIB | N | null | 230016570 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 230001450 | 230000642 | 1.64 | 52 | Palliative (P) | 2016-09-08 | 2016-09-10 | AFLIBERCEPT + FU + IRINOTECAN | 02 | null | 230016762 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 230001451 | 230000642 | 1.75 | 70.5 | Palliative (P) | 2014-12-24 | 2015-09-14 | Docetaxel 75mg/m2 (21 day) | N | N | 230016762 | CAPECITABINE + OXALIPLATIN |
| 230001452 | 230000642 | 1.77 | 85.9 | Curative (C) | 2017-11-27 | 2017-12-13 | CAPECITABINE + OXALIPLATIN | N | N | 230016762 | CAPECITABINE + OXALIPLATIN |
| 230001453 | 230000646 | 1.7 | null | null | 2017-12-12 | 2018-02-16 | CYTARABINE | 2 | N | 230017679 | TRASTUZUMAB |
| 230001454 | 230000648 | 1.76 | 73.15 | Curative (C) | 2018-02-23 | 2018-03-02 | Capecitabine | 02 | N | 230018347 | IGEV R |
| 230001455 | 230001297 | 1.58 | 97.9 | Palliative (P) | 2016-01-05 | 2016-01-06 | Capecitabine + Oxaliplatin 21day | null | null | 230018378 | MITOMYCIN INTRAVESICULAR |
| 230001456 | 230001563 | 1.9 | 74 | Palliative (P) | 2015-08-18 | 2015-11-11 | CAPECITABINE + OXALIPLATIN | 02 | N | 230018510 | TRIFLURIDINE + TIPIRACIL |
| 230001457 | 230000651 | 1.86 | 85.9 | Palliative (P) | 2017-09-17 | 2017-10-11 | Irinotecan + Modified De Gramont | N | Y | 230018912 | CABOZANTINIB |
| 230001458 | 230000653 | 1.61 | 69 | Palliative (P) | 2014-05-18 | 2014-06-02 | Carboplatin AUC 2 - 5 | N | N | 230019077 | CAPECITABINE |
| 230001459 | 230000658 | null | 70.3 | Curative (C) | 2018-06-19 | 2018-06-26 | Docetaxel + Trastuzumab (Maint) | N | N | 230019732 | CAPECITABINE + OXALIPLATIN |
| 230001460 | 230000659 | null | null | Palliative (P) | 2017-11-14 | 2017-11-17 | Irinotecan + Modified De Gramont | 02 | Y | 230020093 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001461 | 230000661 | 1.72 | 89 | Palliative (P) | 2017-12-22 | 2017-12-26 | Docetaxel 75mg/m2 (21 day) | N | Y | 230020525 | OXALIPLATIN + MDG |
| 230001462 | 230000662 | 1.86 | 63.4 | Palliative (P) | 2013-11-11 | 2013-11-12 | Oxaliplatin + Modified de Gramont | N | N | 230020870 | CAPECITABINE + OXALIPLATIN |
| 230001463 | 230000665 | 1.64 | 84 | Palliative (P) | 2015-09-22 | 2016-09-18 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 230021348 | CAPECITABINE + OXALIPLATIN |
| 230001464 | 230000672 | 1.8 | 74.6 | Not known (9) | 2015-10-19 | 2015-11-09 | BEVACIZUMAB + FLUOROURACIL | N | N | 230022008 | CETUXIMAB + OXALIPLATIN + MDG |
| 230001465 | 230000673 | 1.8 | 105.5 | Adjuvant (A) | 2017-03-17 | 2017-04-09 | Irinotecan + Modified De Gramont | 02 | Y | 230022136 | FLUOROURACIL |
| 230001466 | 230000675 | 1.53 | 83.9 | Palliative (P) | 2017-06-22 | 2017-10-27 | Sorafenib | N | N | 230022180 | CAPECITABINE + RT |
| 230001467 | 230000675 | 1.68 | 44 | Palliative (P) | 2019-02-19 | 2019-02-27 | IVE | N | N | 230022180 | OXALIPLATIN + MDG |
| 230001468 | 230000678 | 1.75 | 86.2 | Palliative (P) | 2015-07-09 | 2015-07-10 | EOX | 02 | null | 230022553 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001469 | 230000680 | 1.64 | null | null | 2015-04-11 | 2016-06-09 | Carboplatin + Etoposide IV 3 day | N | null | 230022891 | CETUXIMAB + IRINOTECAN + MDG |
| 230001470 | 230000682 | 0 | 80 | Palliative (P) | 2013-12-13 | 2013-12-27 | Oxaliplatin + Modified de Gramont | N | null | 230023028 | OXALIPLATIN + MDG |